Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

COSCIENS Biopharma Inc T.AEZS

COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The Company is also engaged in the development of therapeutic assets and proprietary extraction technology, which is applied to the production of active ingredients from renewable plant resources used in cosmeceutical products (i.e., oat beta glucan and avenanthramides, which are found in skincare product brands like Aveeno and Burt’s Bees formulations) and being developed as potential nutraceuticals and/or pharmaceuticals.


TSX:AEZS - Post by User

Comment by prophetoffactzon Jun 21, 2024 8:56am
95 Views
Post# 36099602

RE:RE:Merger Vote

RE:RE:Merger Vote"see CZOs share price down to 14 or 15 cent range tells me they have failed in that duty."

That can change in a day. Give us your numbers for sensitivity and specificity for the diagnostic test. The trial has treated the last patient and we are about to get the results. This is the basis for a potential deal and the previous Strongbridge deal was significant.

PGX is also expected to be commissioned at the 50L and 100L scale in the next three months. Give us your numbers and expectation. Give us your numers for a deal based on the results.

Unfortunatly, we are in an information vaccuum until the key data hits. There is more info than the above too. 



<< Previous
Bullboard Posts
Next >>